TNFRSF4 CLIA Kit
-
- Target Alle TNFRSF4 CLIA Kits anzeigen
- TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
-
Reaktivität
- Maus
- Nachweismethode
- Chemiluminescent
- Methodentyp
- Sandwich ELISA
- Detektionsbereich
- 15.62 pg/mL - 1000 pg/mL
- Untere Nachweisgrenze
- 15.62 pg/mL
- Applikation
- ELISA
- Verwendungszweck
- Mouse Tumor Necrosis Factor Receptor Superfamily Member 4 (TNFRSF4) CLIA Kit is a Sandwich CLIA Kit for use with Serum, plasma, tissue homogenates and other biological fluids.
- Proben
- Plasma, Serum, Tissue Homogenate
- Analytische Methode
- Quantitative
- Sensitivität
- < 6.7 pg/mL
- Featured
- Zu unserem meistverkauften TNFRSF4 ELISA Kit
- Top Product
- Discover our top product TNFRSF4 ELISA Kit
-
-
- Applikationshinweise
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
- Plattentyp
- Pre-coated
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
- Haltbarkeit
- 6 months
-
- Target Alle TNFRSF4 CLIA Kits anzeigen
- TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
- Andere Bezeichnung
- TNFRSF4 (TNFRSF4 Produkte)
- Synonyme
- TNFRSF4 CLIA Kit, ACT35 CLIA Kit, CD134 CLIA Kit, Ly-70 CLIA Kit, Ox40 CLIA Kit, TXGP1L CLIA Kit, Txgp1 CLIA Kit, OX40 CLIA Kit, TNF receptor superfamily member 4 CLIA Kit, tumor necrosis factor receptor superfamily, member 4 CLIA Kit, TNFRSF4 CLIA Kit, Tnfrsf4 CLIA Kit
- Pathways
- Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-